ISIN | CH1205452688 |
---|---|
Valor Number | 120545268 |
Bloomberg Global ID | |
Fund Name | Bellevue Healthcare Strategy I2 EUR |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 945.05 EUR | 03.07.2025 |
---|---|---|
Previous Price * | 944.09 EUR | 02.07.2025 |
52 Week High * | 1,084.57 EUR | 30.08.2024 |
52 Week Low * | 914.32 EUR | 07.04.2025 |
NAV * | 945.05 EUR | 03.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 134,785,728 | |
Unit/Share Assets *** | 41,651,527 | |
Trading Information SIX |
YTD Performance | -7.93% |
31.12.2024 - 03.07.2025
31.12.2024 03.07.2025 |
---|---|---|
YTD Performance (in CHF) | -8.40% |
31.12.2024 - 03.07.2025
31.12.2024 03.07.2025 |
1 month | -1.73% |
03.06.2025 - 03.07.2025
03.06.2025 03.07.2025 |
3 months | -3.47% |
03.04.2025 - 03.07.2025
03.04.2025 03.07.2025 |
6 months | -8.75% |
03.01.2025 - 03.07.2025
03.01.2025 03.07.2025 |
1 year | -6.52% |
03.07.2024 - 03.07.2025
03.07.2024 03.07.2025 |
2 years | -1.81% |
03.07.2023 - 03.07.2025
03.07.2023 03.07.2025 |
3 years | -5.25% |
06.10.2022 - 03.07.2025
06.10.2022 03.07.2025 |
5 years | - | - |
Equity Participation Rate in % | 94.16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Elevance Health Inc | 2.97% | |
---|---|---|
AbbVie Inc | 2.96% | |
The Cigna Group | 2.96% | |
Abbott Laboratories | 2.94% | |
McKesson Corp | 2.94% | |
Vertex Pharmaceuticals Inc | 2.92% | |
Eli Lilly and Co | 2.92% | |
Boston Scientific Corp | 2.90% | |
HCA Healthcare Inc | 2.88% | |
Encompass Health Corp | 2.87% | |
Last data update | 31.05.2025 |
TER | 0.61% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |